LAURA MIELE: Open Payments
NPI 1508400946 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$418 in 13 payments from 7 companies in 2025. Trend: 2023 $126 · 2024 $636 · 2025 $418
Food & beverage: $418
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $141 |
| La Jolla Pharmaceutical Company | 1 | $129 |
| Merck Sharp & Dohme LLC | 3 | $54 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $22 |
| Melinta Therapeutics, LLC | 1 | $22 |
Products named: ZEVTERA, AVYCAZ, XERAVA, VOWST, NUZYRA, Kimyrsa, GARDASIL 9, ZERBAXA.
Industry payments across OH — which companies pay providers there.
